Sunitinib Malate Capsules 12.5mg Third Party Manufacturing | Medizia Biotech

Medizia Biotech is a trusted name in Sunitinib Malate Capsules 12.5mg Third Party Manufacturing in India, offering high-quality oncology medicines manufactured under stringent quality standards. We provide reliable contract manufacturing solutions for pharmaceutical companies, healthcare organizations, hospitals, wholesalers, distributors, and exporters seeking premium oncology products.

Sunitinib Malate Capsules 12.5mg is a targeted anticancer medicine widely prescribed for the treatment of renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET) under the supervision of qualified oncologists. At Medizia Biotech, every batch is produced using quality-approved raw materials and advanced manufacturing processes to ensure safety, consistency, and efficacy.

Our modern manufacturing facilities follow WHO-GMP compliant quality systems with strict quality control and quality assurance procedures. We support third party manufacturing, private labeling, custom packaging, bulk manufacturing, and export-oriented production while maintaining international pharmaceutical standards.

Why Choose Medizia Biotech?

• Trusted Sunitinib Malate Capsules 12.5mg Manufacturer in India
• High-quality oncology pharmaceutical manufacturing
• WHO-GMP compliant manufacturing practices
• Third party manufacturing with customized packaging
• Private label and contract manufacturing solutions
• Bulk production with timely delivery
• Export-quality pharmaceutical products
• Competitive pricing and reliable supply chain
• Experienced regulatory and production support

Medizia Biotech is committed to delivering premium oncology formulations with consistent quality, professional service, and dependable manufacturing support for domestic and international pharmaceutical businesses.